9480 Stock Overview
Engages in the development and marketing of imaging solutions for magnetic resonance imaging (MRI) in Sweden, the Middle East, Africa, Europe, North America, South America, and the Asia-Pacific.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
SyntheticMR AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.97 |
| 52 Week High | SEK 2.28 |
| 52 Week Low | SEK 0.93 |
| Beta | 1.01 |
| 11 Month Change | -13.75% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -73.61% |
Recent News & Updates
Recent updates
Shareholder Returns
| 9480 | DE Healthcare Services | DE Market | |
|---|---|---|---|
| 7D | 0% | 5.6% | 4.5% |
| 1Y | n/a | 17.0% | 13.4% |
Return vs Industry: Insufficient data to determine how 9480 performed against the German Healthcare Services industry.
Return vs Market: Insufficient data to determine how 9480 performed against the German Market.
Price Volatility
| 9480 volatility | |
|---|---|
| 9480 Average Weekly Movement | 13.8% |
| Healthcare Services Industry Average Movement | 5.6% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 11.6% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 9480's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 9480's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 43 | Ulrik Harrysson | www.syntheticmr.com |
SyntheticMR AB (publ) engages in the development and marketing of imaging solutions for magnetic resonance imaging (MRI) in Sweden, the Middle East, Africa, Europe, North America, South America, and the Asia-Pacific. Its SyMRI delivers various contrast images, biomarker segmentations, and quantitative data with a single MR sequence. The company also offers SyMRI NEURO includes contrast weighted images, as well as biomarker segmentation, volumetric measurements of brain tissues and parametric maps that provide objective decision support for the diagnosis and follow-up of patients; SyMRI MSK works on a range of anatomies, and provides quantitative T1, T2, and PD maps, as well as multiple contrast-weighted images; and MAGiC, a customer-specific version of SyMRI IMAGE.
SyntheticMR AB (publ) Fundamentals Summary
| 9480 fundamental statistics | |
|---|---|
| Market cap | €102.42m |
| Earnings (TTM) | €4.72m |
| Revenue (TTM) | €86.99m |
0.0x
P/E Ratio0.0x
P/S RatioIs 9480 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 9480 income statement (TTM) | |
|---|---|
| Revenue | SEK 86.99m |
| Cost of Revenue | SEK 29.58m |
| Gross Profit | SEK 57.42m |
| Other Expenses | SEK 52.69m |
| Earnings | SEK 4.72m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.11 |
| Gross Margin | 66.00% |
| Net Profit Margin | 5.43% |
| Debt/Equity Ratio | 0% |
How did 9480 perform over the long term?
See historical performance and comparison